Recruiting Schizophrenia Studies in Culver City
About Schizophrenia Clinical Trials in Culver City
Schizophrenia is a chronic brain disorder affecting approximately 2.8 million US adults, characterized by hallucinations, delusions, disorganized thinking, and cognitive difficulties. While current treatments rely primarily on first- and second-generation antipsychotics (risperidone, olanzapine, clozapine), many patients experience incomplete symptom relief or significant side effects. Clinical trials are testing novel mechanisms including muscarinic receptor agonists (like KarXT/xanomeline-trospium), trace amine-associated receptor 1 (TAAR1) agonists, glutamate modulators, and long-acting injectable formulations. Treatment-resistant schizophrenia remains a major focus area, with trials seeking patients who have not adequately responded to standard antipsychotic therapy.
There are currently 10 schizophrenia clinical trials recruiting participants in Culver City, CA. These studies are seeking a combined 4,488 participants. Research is being sponsored by LB Pharmaceuticals Inc., Neurocrine Biosciences, MapLight Therapeutics and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Schizophrenia Clinical Trials in Culver City — FAQ
Are there schizophrenia clinical trials in Culver City?
Yes, there are 10 schizophrenia clinical trials currently recruiting in Culver City, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Culver City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Culver City research site will contact you about next steps.
Are clinical trials in Culver City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Culver City studies also compensate for your time and travel.
What schizophrenia treatments are being tested?
The 10 active trials in Culver City are testing new therapies including novel drugs, biologics, and treatment approaches for schizophrenia.
Data updated October 12, 2026 from ClinicalTrials.gov